Skip to content
Government Federal, Transport Automotive

***MEDIA ALERT*** EVs becoming more affordable for everyday Australians, whilst hybrid to play a greater role in vehicle electrification

NALSPA < 1 mins read

The National Automotive Leasing and Salary Packaging Association (NALSPA) will co-host a Parliamentary Friends of Electric Vehicles event that will highlight the changing EV landscape in Australia and notably the rise in popularity of low-emissions plug-in hybrid vehicles (PHEVS), as well as initiatives that are making EVs more affordable for everyday Australians and challenges that lie ahead.

The event will also feature a display of some of the latest BEV and PHEV models in Australia, showcased outside of Parliament House.

WHO:

  • Parliamentary Friends of Electric Vehicles co-chairs Dr Michelle Ananda-Rajah MP and Dr Monique Ryan MP, and Speaker of the House, the Hon Milton Dick MP
  • Electric Vehicle Council CEO, Samantha Johnson
  • Federal Chamber of Automotive Industries CEO, Tony Weber
  • NALSPA CEO, Rohan Martin


WHEN: Wednesday October 9. Car display from 7.30am. Speeches from 9.20am


WHERE:

  • Car display: Senate Entrance, Southern Drop Off Zone, Parliament Drive
  • Speeches: Speakers Courtyard, RG44, Parliament House, Canberra

NALSPA CEO Rohan Martin said: “Australians living in the outer suburbs and regional areas are embracing EVs, with plug-in hybrids experiencing a notable rise in sales – importantly with the assistance of government policy. PHEVs act as an essential bridge to full electric driving.

“While BEV model availability and charging infrastructure is improving, plug-in hybrids provide a practical solution for motorists who are concerned about driving range or want a larger car that’s not yet available in pure EV form, all while enjoying the benefits of lower running costs and emissions.

“Particularly amidst a cost-of-living crisis, ongoing government support to encourage PHEVs supply and take-up, along with BEVs, is critical to maintain affordability for cleaner versions of the types of vehicles Australians want to drive, while advancing the nation’s emissions reduction goals.”

Media contact: Sofie Wainwright 0403 920 301

More from this category

  • Government Federal
  • 23/12/2025
  • 10:26
Catholic Health Australia

Hospital group backs private national efficient price

The country's largest not-for-profit hospital group has united to back the government’s proposal for a Private National Efficient Price (PNEP), calling it a crucial reform to restore fairness, transparency, and stability to private hospital funding. The private hospitals CEOs Group, representing 63 non-profit hospitals, has strongly endorsed the proposal. They include Catholic Health Australia (CHA), St Vincent’s Health Australia, St John of God Health Care, Mater, Cabrini, Calvary Health Care, St Vincent’s Private Lismore, Canossa, and UnitingCare Queensland hospitals. “For too long, private hospitals have been constrained by an opaque and inefficient contracting system that risks the future delivery of…

  • Transport Automotive
  • 22/12/2025
  • 20:26
OAG Aviation Worldwide

South Korea’s Jeju (CJU)-Seoul Gimpo (GMP) is the World’s Busiest Airline Route in 2025, Latest OAG Data Reveals

An average of 39,000 seats per day operate on the world’s top routeKey findings:14.4 million seats were scheduled between Jeju (CJU)-Seoul Gimpo (GMP) in 2025.Asia Pacific dominates, accounting for 9/10 of the top routes globally.Hong Kong (HKG) – Taipei (TPE) continues to be the busiest cross-border route.Jeddah (JED) – Riyadh (RUH) is the fastest growing top ten route YoY: +13% seats vs 2024.LONDON, Dec. 22, 2025 (GLOBE NEWSWIRE) -- OAG, the leading data platform for the global travel industry, today revealed its ranking of 2025’s Busiest Airline Routes. The analysis is powered by OAG's Global Airline Schedules Data and provides an…

  • Transport Automotive
  • 22/12/2025
  • 19:11
Merck

Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor

First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER study In MANEUVER, pimicotinib significantly improved objective…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.